Mobile App-Supported Education for Diabetes Management in Adolescents With Type 1 Diabetes (T1DM-APP)

March 24, 2026 updated by: Deniz Akkaya Balcı

The Effect of Mobile Application-Supported Education Based on the Health Promotion Model on Diabetes Management in Adolescents With Type 1 Diabetes Mellitus

This randomized controlled study aims to evaluate the effect of mobile application-supported education based on the Health Promotion Model on diabetes management in adolescents aged 12-18 years with Type 1 Diabetes Mellitus. The study will be conducted in a pediatric endocrinology clinic. Participants will be randomly assigned to intervention and control groups. The intervention group will receive mobile application-based diabetes education, while the control group will receive standard care. Outcomes of the study include diabetes knowledge level, self-efficacy, blood glucose monitoring skills, and HbA1c levels.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

This study is designed as a randomized controlled trial conducted in adolescents diagnosed with Type 1 Diabetes Mellitus. The intervention is based on the Health Promotion Model and delivered through a mobile application including educational modules and interactive content. Data will be collected using validated scales and clinical parameters such as HbA1c. The effectiveness of the intervention will be evaluated through pre-test, post-test, and follow-up measurements.

Study Type

Interventional

Enrollment (Actual)

96

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Adolescents aged between 12 and 18 years

    • Diagnosed with Type 1 Diabetes Mellitus
    • Able to use a smartphone
    • Willing to participate in the study
    • Provided informed consent (from parents/guardians if under 18)

Exclusion Criteria:

Presence of any severe chronic disease other than Type 1 Diabetes

  • Cognitive or psychiatric conditions that may affect participation
  • Participation in another intervention study
  • Inability to use a mobile application

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention Group
Participants will receive mobile application-supported education based on the Health Promotion Model
Behavioral: Mobile Application-Supported Education
A mobile application-based education program developed according to the Health Promotion Model to improve diabetes management in adolescents.
No Intervention: Control Group
Participants will receive standard care without additional mobile application-supported education.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Diabetes Management Self-Efficacy Score
Time Frame: Baseline and 3 months after intervention
Self-efficacy levels of adolescents will be assessed using a validated scale.
Baseline and 3 months after intervention
Diabetes Management Self-Efficacy Score
Time Frame: Baseline and 3 months after intervent
Self-efficacy levels of adolescents with type 1 diabetes will be measured using a validated diabetes self-efficacy scale.
Baseline and 3 months after intervent

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Deniz Akkaya Balcı

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 10, 2024

Primary Completion (Actual)

December 10, 2024

Study Completion (Actual)

November 10, 2025

Study Registration Dates

First Submitted

March 20, 2026

First Submitted That Met QC Criteria

March 24, 2026

First Posted (Actual)

March 30, 2026

Study Record Updates

Last Update Posted (Actual)

March 30, 2026

Last Update Submitted That Met QC Criteria

March 24, 2026

Last Verified

March 1, 2026

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • T1DM-APP-2024

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Individual participant data will not be shared due to privacy and ethical considerations.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Type 1 Diabetes Mellitus

Clinical Trials on Mobile Application-Supported Education

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Gambia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe